In 1998, UW–Madison developmental biologist James Thomson introduced the world to the first laboratory-derived human embryonic stem cells. His lab’s accomplishment underpins the new field of regenerative medicine, and the all-purpose cells are used worldwide …
News
Saha receives award for work on retinal mutations
The Harrington Discovery Institute has selected Krishanu Saha, an assistant professor in the Department of Biomedical Engineering, as one of two 2018 Gund-Harrington Scholars. The institute cited Saha’s work using gene editing nanomedicines to correct retinal mutations, …
Bill Murphy to pave new roads to biomanufacturing progress
August 15, 2018 | By Jordana Lenon Beginning this fall, Bill Murphy, Ph.D., Harvey D. Spangler professor of biomedical engineering and professor of orthopedics and rehabilitation, joins a new state biomanufacturing initiative to advance stem cell, …
Everyday Remarkable: Behind the Scenes with Scientist Jianhua Zhang, PhD
Jianhua Zhang, PhD, senior scientist, Cardiovascular Medicine, first learned about Marie Curie’s story and discoveries while studying chemistry in middle school. Years later, Dr. Zhang’s work is still guided by a quote from Curie: “Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less.”
“That’s my whole motivation, passion and interest in doing research, particularly now in the era of stem cell research,” said Dr. Zhang.
Stem cells shine as Morgridge’s rural summer science camps are now underway
Every summer since 2007, students from some of the smallest high schools in Wisconsin have descended on the Morgridge Institute for Research at the University of Wisconsin–Madison for some big-time scientific immersion. The Morgridge Rural Summer Science …
Cell therapy is the future, and Wisconsin is the place, UW-Madison expert tells Technology Council
Medicine is rapidly approaching a great advance that will augment or replace drugs with human cells for treating a range of intractable conditions, an expert in cell therapy told the Wisconsin Technology Council on June …
Study points researchers toward new therapies for fragile X syndrome
New insights into the molecular machinations behind fragile X syndrome, the most common inherited intellectual disability, may help researchers develop potential therapies. Fragile X is a genetic condition that affects one in 4,000 males and …
Jing Zhang named Centennial Professor of Oncology
SCRMC member Jing Zhang, PhD, of the McArdle Laboratory for Cancer Research, has been named the new Centennial Professor of Oncology. This professorship, endowed through the University of Wisconsin School of Medicine and Public Health, …
Against the odds: For children with resistant leukemia, immunotherapy offers hope
SCRMC faculty members Dr. Christian Capitini and Dr. Peiman Hematti treat a patient at UW Health’s American Family Children’s Hospital with her own, genetically modified immune cells. The first gene therapy approved in the United States, CAR T therapy is being explored as a treatment for blood cancers that do not respond well to chemotherapy. – By David Wahlberg for the Wisconsin State Journal.
UW researchers identify arterial hemogenic endothelial cells that can function as lymphoid precursors
Scientists at the University of Wisconsin School of Medicine and Public Health have used human stem cells to make blood-forming cells and demonstrated that they can function as lymphoid precursors, or the earliest cells from which various immune cells arise. These findings may be helpful for treating a variety of blood cancers, according to Igor Slukvin, MD, PhD, SCRMC faculty member, professor of pathology and laboratory medicine, and lead scientist of the research studies.